Joanne Stevens

Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist

Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox et al. · Journal of Neurogenetics · 2011 · 270 citations

Medicine, Neuroscience, Pharmacology +16

Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial

W. Joseph Herring, Paulette Ceesay, Ellen Snyder et al. · Alzheimer s & Dementia · 2020 · 186 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Discovery of [(2<i>R</i>,5<i>R</i>)‐5‐{[(5‐Fluoropyridin‐2‐yl)oxy]methyl}‐2‐methylpiperidin‐1‐yl][5‐methyl‐2‐(pyrimidin‐2‐yl)phenyl]methanone (MK‐6096): A Dual Orexin Receptor Antagonist with Potent Sleep‐Promoting Properties

Paul J. Coleman, John D. Schreier, Christopher D. Cox et al. · ChemMedChem · 2012 · 124 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia

Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox et al. · Neuropharmacology · 2011 · 123 citations

Medicine, Medicinal Chemistry, Pharmacology +10

The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold

Anthony L. Gotter, Christopher J. Winrow, Joseph Brunner et al. · BMC Neuroscience · 2013 · 96 citations · Full text

Medicine, Neuroscience, Pharmacology +17